Suspended

MedSentry System's Impact on Medication Adherence in Heart Failure Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to evaluate how well heart failure patients adhere to their medication regimen using the MedSentry System, by asking participants how often they took their medications as prescribed in the past 4 weeks.

What is being tested

MedSentry System

Device
Who is being recruted

Treatment Adherence and Compliance+6

+ Behavior

+ Cardiovascular Diseases

Over 18 Years
+15 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Supportive Care Study

Interventional
Study Start: March 2013
See protocol details

Summary

Principal SponsorMassachusetts General Hospital
Last updated: September 17, 2020
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2013

Actual date on which the first participant was enrolled.

This study focuses on understanding the impact of the MedSentry system, a tool designed to help patients stick to their medication schedule and remember to take their medicines. The research specifically targets patients who have been diagnosed with heart failure. The main aim is to see if using this system can lead to better medication adherence and improved health outcomes. It's also interested in finding out how easy and satisfying the system is to use. The hope is that this study can lead to fewer hospital visits and better quality of life for heart failure patients. During the study, participants will use the MedSentry system to manage their medications. The study will measure how often patients take their medications as prescribed using a simple question from the Medical Outcomes Study (MOS) "Adhere". This question asks participants how often they took their medications as prescribed in the past 4 weeks. The study will then categorize participants as either adherent (most or all of the time) or non-adherent (none, a little, or some of the time).

Principal SponsorMassachusetts General Hospital
Last updated: September 17, 2020
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

26 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Treatment Adherence and ComplianceBehaviorCardiovascular DiseasesHeart DiseasesPatient Acceptance of Health CarePatient ComplianceHealth BehaviorHeart FailureMedication Adherence

Criteria

11 inclusion criteria required to participate
Have a telephone or cell phone

Hospitalization within the last 24 months

Live in the greater Boston area

Patient must have an Massachusetts General Hospital (MGH) affiliated care provider

Show More Criteria

4 exclusion criteria prevent from participating
Awaiting revascularization, cardiac resynchronization or heart transplant

Dementia or other conditions precluding the participant from providing informed consent or from learning to use the MedSentry pillbox

Home environment unsuitable for the MedSentry pillbox and other installed equipment

Patients with a coexisting terminal illness like cancer or Chronic Renal Failure (CRF) requiring dialysis

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

No Intervention
Subjects will continue to receive usual medical care from their doctor(s).

Group II

Experimental
Subjects will continue to receive usual medical care from their doctor(s). Subjects will use the MedSentry System and electronic pillbox, to manage their medications.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Massachusetts General Hospital

Boston, United StatesOpen Massachusetts General Hospital in Google Maps
SuspendedOne Study Center